These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10407053)

  • 1. Cognitive deficits in a genetic mouse model of the most common biochemical cause of human mental retardation.
    Zagreda L; Goodman J; Druin DP; McDonald D; Diamond A
    J Neurosci; 1999 Jul; 19(14):6175-82. PubMed ID: 10407053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavioral profile of severe mental retardation in a genetic mouse model of phenylketonuria.
    Cabib S; Pascucci T; Ventura R; Romano V; Puglisi-Allegra S
    Behav Genet; 2003 May; 33(3):301-10. PubMed ID: 12837019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An olfactory discrimination procedure for mice.
    Mihalick SM; Langlois JC; Krienke JD; Dube WV
    J Exp Anal Behav; 2000 May; 73(3):305-18. PubMed ID: 10866354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer.
    Oh HJ; Park ES; Kang S; Jo I; Jung SC
    Pediatr Res; 2004 Aug; 56(2):278-84. PubMed ID: 15181195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal phenylketonuria syndrome: studies in mice suggest a potential approach to a continuing problem.
    Zeile WL; McCune HC; Musson DG; O'Donnell B; O'Neill CA; Tsuruda LS; Zori RT; Laipis PJ
    Pediatr Res; 2018 Apr; 83(4):889-896. PubMed ID: 29278642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAH(enu2) mouse model of phenylketonuria.
    Dobrowolski SF; Lyons-Weiler J; Spridik K; Vockley J; Skvorak K; Biery A
    Mol Genet Metab; 2016 Sep; 119(1-2):1-7. PubMed ID: 26822703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bone mineralization defect in the Pah
    Dobrowolski SF; Tourkova IL; Robinson LJ; Secunda C; Spridik K; Blair HC
    Mol Genet Metab; 2018 Nov; 125(3):193-199. PubMed ID: 30201326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.
    Winn SR; Scherer T; Thöny B; Ying M; Martinez A; Weber S; Raber J; Harding CO
    Mol Genet Metab; 2018 Jan; 123(1):6-20. PubMed ID: 29331172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics analysis reveals perturbations of cerebrocortical metabolic pathways in the Pah
    Lu LH; Xia ZX; Guo JL; Xiao LL; Zhang YJ
    CNS Neurosci Ther; 2020 Apr; 26(4):486-493. PubMed ID: 31471952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptophan during critical postnatal period improves cognitive performances and promotes dendritic spine maturation in genetic mouse model of phenylketonuria.
    Andolina D; Conversi D; Cabib S; Trabalza A; Ventura R; Puglisi-Allegra S; Pascucci T
    Int J Neuropsychopharmacol; 2011 May; 14(4):479-89. PubMed ID: 21040618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the cognitive effects of diet discontinuation in adults with phenylketonuria (PKU) using pegvaliase therapy in PAH-deficient mice.
    Winn SR; Dudley S; Scherer T; Rimann N; Thöny B; Boutros S; Krenik D; Raber J; Harding CO
    Mol Genet Metab; 2022 May; 136(1):46-64. PubMed ID: 35339387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the Maternal Phenylketonuria Collaborative Study.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 1999 Aug; 104(2 Pt 1):258-62. PubMed ID: 10429004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Lagler FB; Gersting SW; Zsifkovits C; Steinbacher A; Eichinger A; Danecka MK; Staudigl M; Fingerhut R; Glossmann H; Muntau AC
    Biochem Pharmacol; 2010 Nov; 80(10):1563-71. PubMed ID: 20705059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
    Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
    PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice.
    Mochizuki S; Mizukami H; Ogura T; Kure S; Ichinohe A; Kojima K; Matsubara Y; Kobayahi E; Okada T; Hoshika A; Ozawa K; Kume A
    Gene Ther; 2004 Jul; 11(13):1081-6. PubMed ID: 15057263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.
    Kleiman S; Vanagaite L; Bernstein J; Schwartz G; Brand N; Elitzur A; Woo SL; Shiloh Y
    J Med Genet; 1993 Apr; 30(4):284-8. PubMed ID: 8487271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of hypopigmentation in phenylketonuria mice by adenovirus-mediated gene transfer.
    Nagasaki Y; Matsubara Y; Takano H; Fujii K; Senoo M; Akanuma J; Takahashi K; Kure S; Hara M; Kanegae Y; Saito I; Narisawa K
    Pediatr Res; 1999 Apr; 45(4 Pt 1):465-73. PubMed ID: 10203136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell energy deficit and oxidative stress contribute to osteopenia in the Pah
    Dobrowolski SF; Sudano C; Phua YL; Tourkova IL; Spridik K; Goetzman ES; Vockley J; Blair HC
    Mol Genet Metab; 2021 Mar; 132(3):173-179. PubMed ID: 33602601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKU mutation G46S is associated with increased aggregation and degradation of the phenylalanine hydroxylase enzyme.
    Eiken HG; Knappskog PM; Apold J; Flatmark T
    Hum Mutat; 1996; 7(3):228-38. PubMed ID: 8829656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.